Aesculus Hippocastanum L. on Fontan Circulation

Summary

Patients after the Fontan operation at a single institution will be randomized to receive a standardized extract of Aesculus hippocastanum L. (horse chestnut) or placebo for 4 months in a crossover clinical trial. The primary outcome will be the mesenteric artery resistance measured by Dopple sonography.

Timeline

Start

2017-10-31

Primary completion

2020-12-31

Completion

2020-12-31

Outcome

Outcome not reported

Stopped: “The graduate student quit.”

Drugs

Indications